The top 30 PE/MSO surgical platforms are hemorrhaging an estimated $742.7M/yr to cancellations and unfilled OR time. $222.8M of that is recoverable in 60 seconds.
Last updated: June 2025 · Refreshed quarterly · Methodology below
| Rank | Platform | Specialty | Locations | Est. Cases/yr | Est. Annual Leakage ⓘ | Recoverable | Deal Room |
|---|---|---|---|---|---|---|---|
| #1 | United Surgical Partners International (USPI)Largest ASC operator in the US; 480+ ASCs and surgical hospitals across 35 states | Multi-Specialty ASC | 480 | 345,600 | $179.3M
480 locations × 3 ORs × 240 slots/yr × 10.9% cancel × $5,600 avg value × 0.85 confidence = $179.3M/yr gross
|
$53.8M | View Deal Room → |
| #2 | SCA Health (Surgical Care Affiliates)Optum subsidiary; 320+ surgical facilities across 37 states | Multi-Specialty ASC | 320 | 230,400 | $119.5M
320 locations × 3 ORs × 240 slots/yr × 10.9% cancel × $5,600 avg value × 0.85 confidence = $119.5M/yr gross
|
$35.9M | View Deal Room → |
| #3 | AmSurgOne of the largest ASC operators in the US; 250+ ambulatory surgery centers nationally | Multi-Specialty ASC | 250 | 180,000 | $93.4M
250 locations × 3 ORs × 240 slots/yr × 10.9% cancel × $5,600 avg value × 0.85 confidence = $93.4M/yr gross
|
$28.0M | View Deal Room → |
| #4 | HealogicsNation's largest wound care management company; 600+ centers; high procedure volume | Wound Care / Surgical | 600 | 288,000 | $75.4M
600 locations × 2 ORs × 240 slots/yr × 11.0% cancel × $2,800 avg value × 0.85 confidence = $75.4M/yr gross
|
$22.6M | View Deal Room → |
| #5 | Surgery PartnersWelsh, Carson portfolio; 180 surgical facilities across 32 states | Multi-Specialty ASC | 180 | 129,600 | $67.2M
180 locations × 3 ORs × 240 slots/yr × 10.9% cancel × $5,600 avg value × 0.85 confidence = $67.2M/yr gross
|
$20.2M | View Deal Room → |
| #6 | Cardiovascular Associates of America (CVAUSA)Largest independent cardiology MSO; 80 locations across Southeast and Midwest | Cardiology | 80 | 38,400 | $38.0M
80 locations × 2 ORs × 240 slots/yr × 9.4% cancel × $12,400 avg value × 0.85 confidence = $38.0M/yr gross
|
$11.4M | View Deal Room → |
| #7 | Spire Orthopedic PartnersBain Capital portfolio; 45 orthopedic practice locations primarily in New England | Orthopedics | 45 | 21,600 | $16.9M
45 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $16.9M/yr gross
|
$5.1M | View Deal Room → |
| #8 | HOPCo (Healthcare Outcomes Performance Company)Warburg Pincus-backed; physician-led orthopedic MSO spanning 45 practice locations | Orthopedics | 45 | 21,600 | $16.9M
45 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $16.9M/yr gross
|
$5.1M | View Deal Room → |
| #9 | US Heart & VascularPE-backed cardiology and vascular MSO; 30 locations across Texas and the South | Cardiology / Vascular | 30 | 14,400 | $14.3M
30 locations × 2 ORs × 240 slots/yr × 9.4% cancel × $12,400 avg value × 0.85 confidence = $14.3M/yr gross
|
$4.3M | View Deal Room → |
| #10 | OneOncologyGeneral Atlantic-backed; 50+ oncology practice locations nationally; includes surgical oncology | Oncology / Surgical Oncology | 50 | 24,000 | $13.5M
50 locations × 2 ORs × 240 slots/yr × 11.0% cancel × $6,000 avg value × 0.85 confidence = $13.5M/yr gross
|
$4.0M | View Deal Room → |
| #11 | OrthoAlliancePE-backed orthopedic platform; 25 locations across the Midwest and Southeast | Orthopedics | 25 | 12,000 | $9.4M
25 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $9.4M/yr gross
|
$2.8M | View Deal Room → |
| #12 | EyeSouth PartnersOlympus Partners-backed; 66 ophthalmology practice locations across the Southeast and Mid-Atlantic | Ophthalmology | 66 | 31,680 | $9.3M
66 locations × 2 ORs × 240 slots/yr × 10.8% cancel × $3,200 avg value × 0.85 confidence = $9.3M/yr gross
|
$2.8M | View Deal Room → |
| #13 | U.S. Vascular PartnersPE-backed vascular MSO; 20 locations with office-based lab (OBL) model | Vascular Surgery | 20 | 9,600 | $8.6M
20 locations × 2 ORs × 240 slots/yr × 10.8% cancel × $9,800 avg value × 0.85 confidence = $8.6M/yr gross
|
$2.6M | View Deal Room → |
| #14 | U.S. Dermatology Partners90 dermatology practice locations; PE-backed platform targeting surgical derm and MOHS | Dermatology | 90 | 43,200 | $7.7M
90 locations × 2 ORs × 240 slots/yr × 9.5% cancel × $2,200 avg value × 0.85 confidence = $7.7M/yr gross
|
$2.3M | View Deal Room → |
| #15 | US Orthopaedic PartnersFrazier Healthcare-backed; 20 orthopedic locations with ASC ownership model | Orthopedics | 20 | 9,600 | $7.5M
20 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $7.5M/yr gross
|
$2.2M | View Deal Room → |
| #16 | Curalta HealthNorth Haven Capital / Audax-backed multi-specialty ASC platform; 18 locations in the Northeast | Multi-Specialty ASC | 18 | 12,960 | $6.7M
18 locations × 3 ORs × 240 slots/yr × 10.9% cancel × $5,600 avg value × 0.85 confidence = $6.7M/yr gross
|
$2.0M | View Deal Room → |
| #17 | Allied OMSLargest PE-backed OMS platform; 50 locations across the US; doctor-equity model | Oral & Maxillofacial Surgery | 50 | 24,000 | $6.4M
50 locations × 2 ORs × 240 slots/yr × 9.0% cancel × $3,500 avg value × 0.85 confidence = $6.4M/yr gross
|
$1.9M | View Deal Room → |
| #18 | ENT & Allergy AssociatesLargest ENT practice in the US; 40 locations across the Northeast | ENT / Otolaryngology | 40 | 19,200 | $6.4M
40 locations × 2 ORs × 240 slots/yr × 10.3% cancel × $3,800 avg value × 0.85 confidence = $6.4M/yr gross
|
$1.9M | View Deal Room → |
| #19 | U.S. Urology PartnersWelsh, Carson-backed; 35 urology practice locations across the US | Urology | 35 | 16,800 | $5.9M
35 locations × 2 ORs × 240 slots/yr × 10.1% cancel × $4,100 avg value × 0.85 confidence = $5.9M/yr gross
|
$1.8M | View Deal Room → |
| #20 | Beacon Orthopaedics & Sports MedicineIndependent orthopedic platform with PE backing; 15 locations in the Cincinnati/Midwest market | Orthopedics | 15 | 7,200 | $5.6M
15 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $5.6M/yr gross
|
$1.7M | View Deal Room → |
| #21 | Schweiger Dermatology Group65 practice locations; nation's largest MOHS surgery group | Dermatology (MOHS) | 65 | 31,200 | $5.5M
65 locations × 2 ORs × 240 slots/yr × 9.5% cancel × $2,200 avg value × 0.85 confidence = $5.5M/yr gross
|
$1.7M | View Deal Room → |
| #22 | Summit Spine & Joint CentersGeneral Atlantic-backed; 12 spine and orthopedic locations in the Southeast | Spine / Orthopedics | 12 | 5,760 | $5.1M
12 locations × 2 ORs × 240 slots/yr × 11.5% cancel × $9,100 avg value × 0.85 confidence = $5.1M/yr gross
|
$1.5M | View Deal Room → |
| #23 | United Urology GroupWebster Capital-backed; 28 urology locations across Mid-Atlantic and Southeast | Urology | 28 | 13,440 | $4.7M
28 locations × 2 ORs × 240 slots/yr × 10.1% cancel × $4,100 avg value × 0.85 confidence = $4.7M/yr gross
|
$1.4M | View Deal Room → |
| #24 | Cardinal Orthopaedic InstituteIndependent physician-led platform with PE sponsorship; 12 orthopedic locations in Ohio | Orthopedics | 12 | 5,760 | $4.5M
12 locations × 2 ORs × 240 slots/yr × 11.2% cancel × $8,200 avg value × 0.85 confidence = $4.5M/yr gross
|
$1.3M | View Deal Room → |
| #25 | Eye Health AmericaGeneral Atlantic-backed; 30 ophthalmology locations across the Southeast | Ophthalmology | 30 | 14,400 | $4.2M
30 locations × 2 ORs × 240 slots/yr × 10.8% cancel × $3,200 avg value × 0.85 confidence = $4.2M/yr gross
|
$1.3M | View Deal Room → |
| #26 | StrideCare (Vascular)Texas-based PE-backed vascular practice; 6 locations with OBL and surgical capabilities | Vascular Surgery | 6 | 2,880 | $2.6M
6 locations × 2 ORs × 240 slots/yr × 10.8% cancel × $9,800 avg value × 0.85 confidence = $2.6M/yr gross
|
$777K | View Deal Room → |
| #27 | Pinnacle ENT PartnersQuad-C Management-backed; 16 ENT locations across the Mid-Atlantic and Southeast | ENT / Otolaryngology | 16 | 7,680 | $2.6M
16 locations × 2 ORs × 240 slots/yr × 10.3% cancel × $3,800 avg value × 0.85 confidence = $2.6M/yr gross
|
$767K | View Deal Room → |
| #28 | One GIWelsh, Carson-backed GI platform; 22 practice locations with in-office endoscopy suites | Gastroenterology / Endoscopy | 22 | 10,560 | $2.5M
22 locations × 2 ORs × 240 slots/yr × 9.8% cancel × $2,800 avg value × 0.85 confidence = $2.5M/yr gross
|
$739K | View Deal Room → |
| #29 | Elevate ENT PartnersAudax-backed ENT platform; 14 locations with in-office surgical suite model | ENT / Otolaryngology | 14 | 6,720 | $2.2M
14 locations × 2 ORs × 240 slots/yr × 10.3% cancel × $3,800 avg value × 0.85 confidence = $2.2M/yr gross
|
$671K | View Deal Room → |
| #30 | Resolve Pain ConsultantsResolve Partners-backed; 8 pain management locations with interventional procedure suites | Pain Management | 8 | 3,840 | $819K
8 locations × 2 ORs × 240 slots/yr × 13.2% cancel × $1,900 avg value × 0.85 confidence = $819K/yr gross
|
$246K | View Deal Room → |
These estimates are model-derived, not audited. They are directional — intended to help PE operating partners assess OR revenue at risk, not replace a CFO's financial model.
Gross Leakage = Locations × Avg ORs × 240 slots/OR/yr × Cancel Rate × Avg Slot Value × 0.85 confidence
Recoverable = Gross Leakage × 30% fillable share
| Specialty | Cancel Rate | Avg Slot Value | Avg ORs/Location |
|---|---|---|---|
| Multi-Specialty ASC | 10.9% | $5,600 | 3 |
| Cardiology | 9.4% | $12,400 | 2 |
| Cardiology / Vascular | 9.4% | $12,400 | 2 |
| Ophthalmology | 10.8% | $3,200 | 2 |
| Dermatology | 9.5% | $2,200 | 2 |
| Dermatology (MOHS) | 9.5% | $2,200 | 2 |
| Orthopedics | 11.2% | $8,200 | 2 |
| Spine / Orthopedics | 11.5% | $9,100 | 2 |
| ENT / Otolaryngology | 10.3% | $3,800 | 2 |
| Gastroenterology / Endoscopy | 9.8% | $2,800 | 2 |
| Urology | 10.1% | $4,100 | 2 |
| Pain Management | 13.2% | $1,900 | 2 |
| Vascular Surgery | 10.8% | $9,800 | 2 |
| Oral & Maxillofacial Surgery | 9.0% | $3,500 | 2 |
| Oncology / Surgical Oncology | 11.0% | $6,000 | 2 |
| Wound Care / Surgical | 11.0% | $2,800 | 2 |